"Amyloidosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Descriptor ID |
D000686
|
| MeSH Number(s) |
C18.452.845.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amyloidosis".
Below are MeSH descriptors whose meaning is more specific than "Amyloidosis".
This graph shows the total number of publications written about "Amyloidosis" by people in this website by year, and whether "Amyloidosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 4 | 0 | 4 |
| 2015 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 6 | 0 | 6 |
| 2023 | 2 | 0 | 2 |
| 2024 | 5 | 0 | 5 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloidosis" by people in Profiles.
-
Impact of amyloidosis on outcomes after transcatheter aortic valve implantation. Rev Esp Cardiol (Engl Ed). 2025 Oct; 78(10):886-895.
-
Hypopharyngeal Amyloidosis: A Rare Cause of Dysphagia. Laryngoscope. 2025 Jun; 135(6):2086-2088.
-
Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy. Sci Transl Med. 2025 Jan 15; 17(781):eadk3690.
-
Age-related TFEB downregulation in proximal tubules causes systemic metabolic disorders and occasional apolipoprotein A4-related amyloidosis. JCI Insight. 2024 Dec 19; 10(3).
-
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
-
Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of A? amyloidosis. Nat Commun. 2024 May 11; 15(1):3996.
-
AIns (insulin) type amyloidoma of the extremity diagnosed by fine-needle aspiration. Diagn Cytopathol. 2024 May; 52(5):E116-E119.
-
Fine-needle aspiration?of amyloidoma: A critical analysis. Cancer Cytopathol. 2024 Mar; 132(3):179-185.
-
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies. Blood Cancer J. 2023 11 15; 13(1):170.
-
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood. 2023 10 05; 142(14):1208-1218.